612 J ournal of Natural Products, 2004, Vol. 67, No. 4
Zheng et al.
C-25, C-29, C-30); other NMR data, see Tables 1-3; HR-
FABMS (positive ion mode) m/z 1507.6930 [M + Na]+ (calcd
for C69H112O34, 1507.6933).
(1H, dd, J ) 11.7, 4.1 Hz, H-3), 1.63, 1.32, 1.15, 1.13, 1.13,
1.02, 0.91 (each 3H, s, H3 of C-27, C-23, C-24, C-26, C-29, C-30,
C-25); other NMR data, see Tables 1, 2, and 5; MALDI-TOF
MS (positive ion mode) m/z 1259 [M + Na]+, 1275 [M + K]+;
HRFABMS (positive ion mode) m/z 1259.6016 [M + Na]+ (calcd
for C59H96O27, 1259.6037).
Sca biosa p on in C (3): amorphous solid; mp 219-220 °C;
[R]25 -19.3° (c 0.20, MeOH); IR (KBr) νmax 3420, 2926, 1736,
D
1638, 1068 cm-1; 1H NMR (pyridine-d5, 500 MHz) δ 5.42 (1H,
br s, H-12), 3.25 (1H, dd, J ) 11.4, 3.9 Hz, H-3), 3.20 (1H, dd,
J ) 13.7, 3.6 Hz, H-18), 1.27 (6H, s, H3 of C-23, C-27), 1.12
(3H, s, H3 of C-24), 1.09 (3H, s, H3 of C-26), 0.90 (9H, s, H3 of
C-25, C-29, C-30); other NMR data, see Tables 1, 2, and 4;
HRFABMS (positive ion mode) m/z 1537.6992 [M + Na]+ (calcd
for C70H114O35, 1537.7038).
Sca biosa p on in K (11): amorphous solid; mp 220-222 °C;
[R]20 -36.0° (c 0.10, MeOH); IR (KBr) νmax 3430, 2933, 1739,
D
1067 cm-1 ;1H NMR (pyridine-d5, 500 MHz) δ 5.51 (1H, br s,
H-12), 3.57 (1H, t-like, H-19), 3.54 (1H, br s, H-18), 3.29 (1H,
dd, J ) 11.7, 4.1 Hz, H-3), 1.65, 1.28, 1.17, 1.02, 0.93 (each
3H, s, H3 of C-27, C-23, C-24, C-30, C-25), 1.14 (6H, s, H3 of
C-26, C-29); other NMR data, see Tables 1, 2, and 5; MALDI-
TOF MS (positive ion mode) m/z 1391 [M + Na]+, 1407 [M +
K]+; HRFABMS (positive ion mode) m/z 1391.6508 [M + Na]+
(calcd for C64H104O31, 1391.6460).
Sca biosa p on in D (4): amorphous solid; mp 228-229 °C;
[R]25 -11.8° (c 0.17, MeOH); IR (KBr) νmax 3423, 2923,1743,
D
1646, 1247, 1030 cm-1; 1H NMR (pyridine-d5, 500 MHz) δ 5.42
(1H, br s, H-12), 3.22 (1H, H-3), 3.20 (1H, H-18), 1.25 (6H, s,
H3 of C-23, C-27), 1.17 (3H, s, H3 of C-24), 1.10 (3H, s, H3 of
C-26), 0.90 (9H, s, H3 of C-25, C-29, C-30); other NMR data,
see Tables 1, 2, and 4; HRFABMS (positive ion mode) m/z
1243.6066 [M + Na]+ (calcd for C59H96O26, 1243.6088).
Sca biosa p on in E (5): amorphous solid; mp 208-210 °C;
Acid Hyd r olysis a n d Deter m in a tion of th e Absolu te
Con figu r a tion of th e Mon osa cch a r id es. A solution of 1 (10
mg) in 1 M HCl (dioxane-H2O, 1:1, 2 mL) was heated at 100
°C for 2 h. After dioxane was removed, the solution was
extracted with EtOAc (2 mL × 3). The extract was washed
with H2O, dried over MgSO4, and evaporated to give oleanolic
acid (3 mg). The H2O layer was neutralized by passing through
an ion-exchange resin (Amberlite MB-3) column and concen-
trated to furnish a monosaccharide residue. The sugar residue
was dissolved in H2O (1 mL), to which a solution of (S)-(-)-
1-phenylethylamine (8 mg) and Na[BH3CN] (16 mg) in EtOH
(1 mL) were added. The mixture was allowed to stand
overnight, then acidified by addition of glacial HOAc acid (0.3
mL) and evaporated to dryness. The resulting solid was
acetylated with Ac2O anhydride (0.5 mL) in pyridine (0.3 mL)
at 100 °C for 1 h. After co-distillation with toluene, H2O (2
mL) was added to the residue, and the crude mixture was
passed through a Sep-pak Plus C18 cartridge (Waters) and
washed with H2O-MeCN (4:1, 1:1, each 5 mL). The H2O-
MeCN (1:1) eluate contained a mixture of the 1-[(S)-N-acetyl-
R-phenylethylamino]-1-deoxyalditol acetate derivatives of the
monosaccharides, which were identified by co-HPLC analysis
with standard sugars prepared under the same conditions.
HPLC conditions: column, PEGASIL ODS, 4.6 × 150 mm;
solvent, MeCN-H2O (33:67); flow rate, 0.8 mL/min; detection,
UV 230 nm; temperature, 40 °C. The derivatives of d-glucose,
D-xylose, L-rhamnose, and L-arabinose were detected with
retention time of 39.1, 26.4, 44.8, and 25.0 min, respectively.
Sugars in compounds 2-11 were also identified by the same
method.
[R]20 -22.9° (c 0.56, MeOH); IR (KBr) νmax 3295, 2945, 2745,
D
1353 cm-1; H NMR (pyridine-d5, 500 MHz) δ 5.41 (1H, br t,
1
J ) 3.3 Hz, H-12), 3.35 (1H, dd, J ) 11.7, 4.1 Hz, H-3), 3.20
(1H, dd, J ) 13.5, 3.9 Hz, H-18), 1.39 (3H, s, H3 of C-23), 1.26
(3H, s, H3 of C-27), 1.24 (3H, s, H3 of C-24), 1.09 (3H, s, H3 of
C-26), 0.89 (9H, s, H3 of C-25, C-29, C-30); other NMR data,
see Tables 1, 2, and 4; MALDI-TOF MS (positive ion mode)
m/z 1213 [M + Na]+, 1229 [M + K]+; HRFABMS (positive ion
mode) m/z 1213.5944 [M + Na]+ (calcd for C58H94O25, 1213.5982).
Sca biosa p on in F (6): amorphous solid; mp 218-219 °C;
[R]25 -11.1° (c 0.10, MeOH); IR (KBr) νmax 3410, 2926, 1646,
D
1533, 1378, 1043 cm-1; 1H NMR (pyridine-d5, 500 MHz) δ 5.40
(1H, br s, H-12), 3.32 (1H, dd, J ) 11.4, 4.1 Hz, H-3), 3.18
(1H, dd, J ) 13.3, 3.2 Hz, H-18), 1.38 (3H, s, H3 of C-23), 1.25
(3H, s, H3 of C-27), 1.21 (3H, s, H3 of C-24), 1.08 (3H, s, H3 of
C-26), 0.89 (9H, s, H3 of C-25, C-29, C-30); other NMR data,
see Tables 1, 2, and 4; HRFABMS (positive ion mode) m/z
1243.6066 [M + Na]+ (calcd for C59H96O26, 1243.6088).
Sca biosa p on in G (7): amorphous solid; mp 228-230 °C;
[R]21 -20.3° (c 1.28, MeOH); IR (KBr) νmax 3418, 2930,1736,
D
1643, 1380, 1058 cm-1; 1H NMR (pyridine-d5, 500 MHz) δ 5.41
(1H, br t-like, H-12), 3.33 (1H, dd, J ) 11.7, 4.1 Hz, H-3), 3.20
(1H, dd, J ) 13.8, 3.7 Hz, H-18), 1.37 (3H, s, H3 of C-23), 1.26
(3H, s, H3 of C-27), 1.23 (3H, s, H3 of C-24), 1.09 (3H, s, H3 of
C-26), 0.89 (9H, s, H3 of C-25, C-29, C-30); other NMR data,
see Tables 1, 2, and 4; MALDI-TOF MS (positive ion mode)
m/z 1405 [M + Na]+, 1421 [M + K]+; HRFABMS (positive ion
Olea n olic a cid : amorphous solid; mp 275-276 °C; [R]21
D
+82° (c 0.10, MeOH); IR (KBr) νmax 3456, 2940, 1696, 1036
cm-1; spectral data consistent with literature values.18
En zym a tic Hyd r olysis of Sca biosa p on in A (1). 1 (16
mg) dissolved in 0.2 M acetate buffer (pH 4.0, 5 mL) was
incubated with naringinase (Sigma Chemical Co., 32 mg). The
reaction mixture was stirred at 40 °C for 10 h. Then a small
amount of EtOH was added. After concentration, the residue
was purified by silica gel column chromatography (CHCl3-
MeOH-H2O, 10:5:1) to give prosapogenin 1a (8 mg) and
D-glucose. The prosapogenin 1c (2 mg) was obtained when the
incubation was prolonged for 2 weeks.
mode) m/z 1405.6616 [M + Na]+ (calcd for C65H106O31
1405.6613).
,
Sca biosa p on in H (8): amorphous solid; mp 230-232 °C;
[R]20 -11.3° (c 0.10, MeOH); IR (KBr) νmax 3399, 2928, 1731,
D
1646, 1378, 1071 cm-1; 1H NMR (pyridine-d5, 500 MHz) δ 5.54
(1H, br s, H-12), 3.28 (1H, dd, J ) 11.4, 3.9 Hz, H-3), 2.93
(1H, s, H-18), 1.33 (1H, m, H-20), 1.04 (3H, d, J ) 6.4 Hz, H3
of C-30), 1.70, 1.36, 1.29, 1.18, 1.16, 0.94 (each 3H, s, H3 of
C-27, C-29, C-23, C-26, C-24, C-25); other NMR data, see
Tables 1, 2, and 4; MALDI-TOF MS (positive ion mode) m/z
1421 [M + Na]+, 1437 [M + K]+; HRFABMS (positive ion
P r osa p ogen in (1a ): amorphous solid; mp 198-200 °C;
mode) m/z 1421.6602 [M + Na]+ (calcd for C65H106O32
1421.6565).
,
[R]20 -12.3° (c 0.78, MeOH); IR (KBr) νmax 3415, 2938, 1729,
D
1068 cm-1; H NMR (pyridine-d5, 500 MHz) δ 5.44 (1H, br s,
1
Sca biosa p on in I (9): amorphous solid; mp 213-215 °C;
H-12), 3.31 (1H, dd, J ) 11.7, 3.9 Hz, H-3), 3.22 (1H, dd, J )
13.3, 3.7 Hz, H-18), 1.33, 1.29, 1.19, 1.11, 0.93, 0.91, 0.89 (each
3H, s, H3 of C-23, C-27, C-24, C-26, C-29, C-30, C-25); other
NMR data, see Tables 1-3; MALDI-TOF MS (positive ion
mode) m/z 1051 [M + Na]+, 1067 [M + K]+.
[R]20 -15.0° (c 0.10, MeOH); IR (KBr) νmax 3429, 2928, 1730,
D
1070 cm-1 ; 1H NMR (pyridine-d5, 500 MHz) δ 5.55 (1H, br s,
H-12), 3.28 (1H, dd, J ) 11.7, 4.1 Hz, H-3), 2.92 (1H, s, H-18),
1.36 (1H, m, H-20), 1.03 (3H, d, J ) 6.6 Hz, H3 of C-30), 1.69,
1.36, 1.30, 1.17, 1.14, 0.94 (each 3H, s, H3 of C-27, C-29, C-23,
C-26, C-24, C-25); other NMR data, see Tables 1, 2, and 5;
MALDI-TOF MS (positive ion mode) m/z 1259 [M + Na]+, 1275
[M + K]+; HRFABMS (positive ion mode) m/z 1259.6053 [M
+ Na]+ (calcd for C59H96O27, 1259.6036).
Absolu te Con figu r a tion of th e Glu cose by HP LC. The
glucose obtained from compound 1 was determined to be of
D-type ([R]25 +37.8°, c 0.09, 24 h after dissolution in H2O) in
D
comparison with an authentic sample under the following
HPLC conditions: pump, J ASCO-980; detection, Shodex RI-
71; column, Asahi Pak NH2P-50, 4.6 × 150 mm; solvent,
MeCN-H2O (75:25); flow rate, 1.0 mL/min; tR, 11.2 min.
P r osa p ogen in (1c): amorphous solid; mp 249-252 °C;
Sca biosa p on in J (10): amorphous solid; mp 212-214 °C;
[R]20 -6.5° (c 0.10, MeOH); IR (KBr) νmax 3429, 2934, 1729,
D
1646, 1066 cm-1; 1H NMR (pyridine-d5, 500 MHz) δ 5.50 (1H,
s, H-12), 3.56 (1H, t-like, H-19), 3.53 (1H, br s, H-18), 3.28
[R]16 +64.3° (c 0.20, MeOH); IR (KBr) νmax 3427, 2939, 1701,
D